Quality of Life in Glioblastoma Not Worsened by Tumor-Treating Fields Plus Temozolomide
TTFields therapy was associated with significantly greater physical and emotional functioning.
The FDA has granted full approval of Avastin for the treatment of glioblastoma.
Treatment with lomustine plus bevacizumab does not show a survival advantage over treatment with lomustine alone in patients with glioblastoma.
1p/19q non-co-deleted anaplastic gliomas are associated with lower sensitivity to chemotherapy and worse prognosis than 1p/19q co-deleted tumors.